| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |